HDFC Pharma and Healthcare Fund - Growth Option

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-10-2023
Asset Class: Equity
Benchmark: BSE Healthcare Index
Expense Ratio: 2.14% As on (30-12-2024)
Status: Open Ended Schemes
Minimum Investment: 100.0
Minimum Topup: 100.0
Total Assets: 1,577.12 Cr As on (31-12-2024)
Turn over: -
NAV as on 14-01-2025

16.246

0.2 (1.2065%)

CAGR Since Inception

46.4%

BSE Healthcare Index 15.29%

PERFORMANCE of HDFC Pharma and Healthcare Fund - Growth Option

Scheme Performance (%)

Data as on - 14-01-2025

Yearly Performance (%)

Fund Managers

Dhruv Muchhal, Nikhil Mathur

Investment Objective

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

NAV & Lumpsum details( Invested amount 1,00,000)

Show All Monthly Lumpsum Returns
NAV Date NAV Units Market
Value
Returns
(%)
04-10-2023 9.965 10035.1229 100000 0.0 %
06-11-2023 10.067 - 101024 1.02 %
04-12-2023 10.912 - 109503 9.5 %
04-01-2024 11.664 - 117050 17.05 %
05-02-2024 12.161 - 122037 22.04 %
04-03-2024 12.243 - 122860 22.86 %
04-04-2024 12.392 - 124355 24.36 %
06-05-2024 12.683 - 127275 27.27 %
04-06-2024 12.273 - 123161 23.16 %
04-07-2024 13.458 - 135053 35.05 %
05-08-2024 14.543 - 145941 45.94 %
04-09-2024 15.863 - 159187 59.19 %
04-10-2024 16.037 - 160933 60.93 %
04-11-2024 16.297 - 163542 63.54 %
04-12-2024 16.582 - 166402 66.4 %
06-01-2025 16.906 - 169654 69.65 %
14-01-2025 16.246 - 163031 63.03 %

RETURNS CALCULATOR for HDFC Pharma and Healthcare Fund - Growth Option

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

riskometer

Key Performance and Risk Statistics of HDFC Pharma and Healthcare Fund - Growth Option

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
HDFC Pharma and Healthcare Fund - Growth Option - - - - - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of HDFC Pharma and Healthcare Fund - Growth Option

Amount :
Start :
End :
Period
Data as on - 14-01-2025
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
HDFC Pharma and Healthcare Fund - Growth Option 05-10-2023 39.64 0.0 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 36.26 41.05 22.59 29.26 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 32.85 37.28 18.91 26.31 12.85
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 32.46 31.47 15.37 21.96 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 32.05 35.28 20.25 29.24 0.0
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 30.43 36.81 21.31 28.14 13.37
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 29.89 34.53 19.33 26.38 0.0
Kotak Healthcare Fund - Regular Plan - Growth Option 11-12-2023 29.01 0.0 0.0 0.0 0.0
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 28.6 32.82 16.32 27.26 0.0
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 28.45 32.03 17.01 0.0 0.0

PORTFOLIO ANALYSIS of HDFC Pharma and Healthcare Fund - Growth Option

Asset Allocation (%)

Allocation Percentage (%)

Market Cap Distribution

Small Cap

37.85%

Others

1.97%

Large Cap

36.83%

Mid Cap

23.35%

Total

100%